JP2021535174A5 - - Google Patents

Info

Publication number
JP2021535174A5
JP2021535174A5 JP2021512242A JP2021512242A JP2021535174A5 JP 2021535174 A5 JP2021535174 A5 JP 2021535174A5 JP 2021512242 A JP2021512242 A JP 2021512242A JP 2021512242 A JP2021512242 A JP 2021512242A JP 2021535174 A5 JP2021535174 A5 JP 2021535174A5
Authority
JP
Japan
Prior art keywords
lung
transplant rejection
disease
group
chronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535174A (ja
JP7383696B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/049342 external-priority patent/WO2020051139A1/en
Publication of JP2021535174A publication Critical patent/JP2021535174A/ja
Publication of JP2021535174A5 publication Critical patent/JP2021535174A5/ja
Application granted granted Critical
Publication of JP7383696B2 publication Critical patent/JP7383696B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021512242A 2018-09-04 2019-09-03 Jak阻害剤としての5員~7員の複素環アミド Active JP7383696B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862726583P 2018-09-04 2018-09-04
US62/726,583 2018-09-04
PCT/US2019/049342 WO2020051139A1 (en) 2018-09-04 2019-09-03 5 to 7 membered heterocyclic amides as jak inhibitors

Publications (3)

Publication Number Publication Date
JP2021535174A JP2021535174A (ja) 2021-12-16
JP2021535174A5 true JP2021535174A5 (cg-RX-API-DMAC7.html) 2022-08-17
JP7383696B2 JP7383696B2 (ja) 2023-11-20

Family

ID=68051893

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021512242A Active JP7383696B2 (ja) 2018-09-04 2019-09-03 Jak阻害剤としての5員~7員の複素環アミド

Country Status (20)

Country Link
US (2) US10836763B2 (cg-RX-API-DMAC7.html)
EP (1) EP3837010B1 (cg-RX-API-DMAC7.html)
JP (1) JP7383696B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210056380A (cg-RX-API-DMAC7.html)
CN (1) CN112703037B (cg-RX-API-DMAC7.html)
AR (1) AR116114A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019335200A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021004063A2 (cg-RX-API-DMAC7.html)
CL (1) CL2021000515A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021002976A2 (cg-RX-API-DMAC7.html)
EA (1) EA202190686A1 (cg-RX-API-DMAC7.html)
ES (1) ES2955717T3 (cg-RX-API-DMAC7.html)
IL (1) IL281150B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021002484A (cg-RX-API-DMAC7.html)
PH (1) PH12021550324A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202101751XA (cg-RX-API-DMAC7.html)
TW (1) TWI793365B (cg-RX-API-DMAC7.html)
UA (1) UA127328C2 (cg-RX-API-DMAC7.html)
WO (1) WO2020051139A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202100990B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3161899A4 (en) 2014-06-30 2017-12-27 Black & Decker Inc. Battery pack for a cordless power tools
TWI710560B (zh) 2015-11-03 2020-11-21 美商施萬生物製藥研發Ip有限責任公司 用於治療呼吸疾病之jak激酶抑制劑化合物
TWI754019B (zh) 2017-03-09 2022-02-01 美商施萬生物製藥研發 Ip有限責任公司 含有4員雜環醯胺之jak抑制劑
BR112021004063A2 (pt) * 2018-09-04 2021-05-25 Theravance Biopharma R&D Ip, Llc amidas heterocíclicas com 5 a 7 membros como inibidores de jak
BR112021004087A2 (pt) 2018-09-04 2021-05-25 Theravance Biopharma R&D Ip, Llc processo para preparar inibidores de jak e seus intermediários
DK3837258T3 (da) 2018-09-04 2024-07-22 Theravance Biopharma R&D Ip Llc Dimethyl amino azetidine amides as jak inhibitors
KR20220149585A (ko) 2020-03-02 2022-11-08 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 Jak 억제제 화합물의 결정성 수화물
WO2022081872A1 (en) * 2020-10-16 2022-04-21 Gb008, Inc. Janus kinase inhibitors
TW202317550A (zh) 2021-06-25 2023-05-01 美商施萬生物製藥研發 Ip有限責任公司 作為jak抑制劑之咪唑吲唑化合物
CN118401508A (zh) * 2021-12-17 2024-07-26 株式会社大熊制药 (2R,3S)-2-(3-(4,5-二氯-1H-苯并[d]咪唑-1-基)丙基)哌啶-3-醇的新酸加成盐及晶形
AU2025221563A1 (en) * 2024-02-14 2026-07-09 Almirall, S.A. Stat6 inhibitors and methods of use thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI262914B (en) 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
US7872014B2 (en) 2003-07-23 2011-01-18 Exelixis, Inc. Anaplastic lymphoma kinase modulators and methods of use
US20050090529A1 (en) 2003-07-31 2005-04-28 Pfizer Inc 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
US7884109B2 (en) 2005-04-05 2011-02-08 Wyeth Llc Purine and imidazopyridine derivatives for immunosuppression
US8648069B2 (en) 2007-06-08 2014-02-11 Abbvie Inc. 5-substituted indazoles as kinase inhibitors
EP2740731B1 (en) 2007-06-13 2016-03-23 Incyte Holdings Corporation Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
PE20110063A1 (es) 2008-06-20 2011-02-16 Genentech Inc DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
JP2010111624A (ja) 2008-11-06 2010-05-20 Shionogi & Co Ltd Ttk阻害作用を有するインダゾール誘導体
CA2756989A1 (en) 2009-04-03 2010-10-07 Douglas Burdi Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
SMT201700581T1 (it) 2009-12-21 2018-01-11 Samumed Llc 1h-pirazolo[3,4-b]piridine e loro usi terapeutici
US8575336B2 (en) * 2011-07-27 2013-11-05 Pfizer Limited Indazoles
LT3077395T (lt) 2013-12-05 2018-02-12 Pfizer Inc. Pirolo[2,3-d]pirimidinilo, pirolo[2,3-b]pirazinilo ir pirolo[2,3-d]piridinilo akrilamidai
PE20161475A1 (es) 2014-05-14 2017-01-08 Pfizer Pirazolopiridinas y pirazolopirimidinas
WO2016026078A1 (en) 2014-08-19 2016-02-25 Changzhou Jiekai Pharmatech Co., Ltd. Heterocyclic compounds as erk inhibitors
KR101663277B1 (ko) 2015-03-30 2016-10-06 주식회사 녹십자 TNIK, IKKε 및 TBK1 억제제로서의 피라졸계 유도체 및 이를 포함하는 약학적 조성물
TWI710560B (zh) 2015-11-03 2020-11-21 美商施萬生物製藥研發Ip有限責任公司 用於治療呼吸疾病之jak激酶抑制劑化合物
EP3831830A1 (en) * 2015-11-03 2021-06-09 Topivert Pharma Limited 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors
DK3712152T3 (da) * 2015-11-03 2021-03-22 Topivert Pharma Ltd 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus kinase-inhibitorer
US10906888B2 (en) * 2016-07-14 2021-02-02 Pfizer Inc. Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
TWI754019B (zh) * 2017-03-09 2022-02-01 美商施萬生物製藥研發 Ip有限責任公司 含有4員雜環醯胺之jak抑制劑
AU2018261588A1 (en) 2017-05-01 2019-10-31 Theravance Biopharma R&D Ip, Llc Methods of treatment using a JAK inhibitor compound
EP3619208B1 (en) 2017-05-01 2023-06-07 Theravance Biopharma R&D IP, LLC Crystalline forms of a jak inhibitor compound
AR111495A1 (es) 2017-05-01 2019-07-17 Theravance Biopharma R&D Ip Llc Compuestos de imidazo-piperidina fusionada como inhibidores de jak
BR112021004087A2 (pt) 2018-09-04 2021-05-25 Theravance Biopharma R&D Ip, Llc processo para preparar inibidores de jak e seus intermediários
DK3837258T3 (da) 2018-09-04 2024-07-22 Theravance Biopharma R&D Ip Llc Dimethyl amino azetidine amides as jak inhibitors
BR112021004063A2 (pt) * 2018-09-04 2021-05-25 Theravance Biopharma R&D Ip, Llc amidas heterocíclicas com 5 a 7 membros como inibidores de jak
EP3853229A1 (en) 2018-10-29 2021-07-28 Theravance Biopharma R&D IP, LLC 2-azabicyclo hexane compound as jak inhibitor
KR102873783B1 (ko) 2019-02-25 2025-10-21 메디노 파마슈티컬 테크놀로지 (주하이) 컴퍼니 리미티드 Jak 억제제 화합물 및 그 사용
UA130579C2 (uk) 2019-03-05 2026-03-25 Інсайт Корпорейшн Інгібітори шляхів jak1 для лікування хронічної дисфункції алотрансплантата легень
CN112279848A (zh) 2019-07-25 2021-01-29 四川海思科制药有限公司 一种泛JAKs抑制剂及其用途

Similar Documents

Publication Publication Date Title
JP2021535177A5 (cg-RX-API-DMAC7.html)
JP2023516640A5 (cg-RX-API-DMAC7.html)
FI3837258T3 (fi) Dimetyyliaminoatsetidiiniamideja jak-estäjinä
JP2020510010A5 (cg-RX-API-DMAC7.html)
JP2020510015A5 (cg-RX-API-DMAC7.html)
RU2016114866A (ru) Замещенные аминопиримидиновые соединения и способы их использования
JP2018522823A5 (cg-RX-API-DMAC7.html)
JP2019520396A5 (cg-RX-API-DMAC7.html)
JP2012530703A5 (cg-RX-API-DMAC7.html)
RU2003133448A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора
JP2019510787A5 (cg-RX-API-DMAC7.html)
CN104822680A (zh) 咪唑并吡啶化合物
JP2013514356A (ja) ピロロ[2,3−d]ピリミジン化合物
JP2009532417A5 (cg-RX-API-DMAC7.html)
JP2018528182A (ja) 6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジオール及び6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジアミンを調製する方法
JP2020518582A5 (cg-RX-API-DMAC7.html)
JP2020500869A5 (cg-RX-API-DMAC7.html)
RU2006101541A (ru) Производные пиперазина и способ их применения
CN1658877B (zh) 碱性非肽缓激肽拮抗剂及其药物组合物
JP2023504542A5 (cg-RX-API-DMAC7.html)
TW200307545A (en) Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
JP2024524214A5 (cg-RX-API-DMAC7.html)
JP2022526604A5 (cg-RX-API-DMAC7.html)
JP3218243B2 (ja) ベンズイミダゾール、その製造および使用法
JP2006517976A5 (cg-RX-API-DMAC7.html)